About the Northern Ireland Centre for Stratified Medicine

Our Centre is based in the Clinical Translational Research and Innovation Centre (C-TRIC) on the Altnagelvin Hospital site in Derry/Londonderry.

The Northern Ireland Centre for Stratified Medicine aims to identify how our genes or patterns in levels and state of molecules within our bodies, or subtle differences in medical images, could be used to create robust clinical decision making tests for a range of degenerative diseases.

We have the largest single critical mass of researchers solely focused on stratified medicine in Ireland.  We have 23 Core staff, 19 PhD students, and 36 NHS Clinicians affiliated to our Research centre inkling General Practitioners (GPs) and  NHS Health Trusts (predominantly from the Western Health & Social care Trust at Altnagelvin Hospital).

In addition to our own core team of molecular biologists, clinicians and bioinformaticians/data scientists,  we also work closely with the Intelligent Systems Research Centre within our Faculty of Computing & Engineering, particularly in relation to advanced data analytics.

The Centre was established in Autumn 2013 following an award of £11.5M (from European Union Regional Development Fund (ERDF) EU Sustainable Competitiveness Programme for N. Ireland, InvestNI,  the Northern Ireland Public Health Agency (HSC R&D), ILEX & Ulster University) to Professor Tony Bjourson (Director).

What is Stratified Medicine?

Stratified medicine (also known as personalised or precision medicine) is an approach which subdivides patients into groups based on their risk of developing specific diseases or their response to particular therapies. Stratified medicine is recognised as a key global priority for healthcare providers, pharmaceutical and diagnostic industries and patients. The ultimate aim of a stratified approach to medicine is to enable healthcare professionals to provide the 'right treatment, for the right person, at the right time.'

Stratified Medicine relies on using biological markers to separate patients into specific groups for diagnosing and treating disease at much earlier time points than currently possible. In order to realise the potential benefits of stratified medicine, advances in technologies and systems are required to reliably predict disease, select the best treatment and reduce side effects for each individual patient.